Literature DB >> 25119647

Virus-like particles from Escherichia Coli-derived untagged papaya ringspot virus capsid protein purified by immobilized metal affinity chromatography enhance the antibody response against a soluble antigen.

Jesús Guerrero-Rodríguez1, Carlos Alberto Manuel-Cabrera, Y Apatzingan Palomino-Hermosillo, Paola Guadalupe Delgado-Guzmán, Martha Escoto-Delgadillo, Laura Silva-Rosales, Sara Elisa Herrera-Rodríguez, Carla Sánchez-Hernández, Abel Gutiérrez-Ortega.   

Abstract

There is a growing interest in using virus-like particles (VLPs) as scaffolds for the presentation of antigens of choice to the immune system. In this work, VLPs from papaya ringspot virus capsid protein expressed in Escherichia coli were evaluated as enhancers of antibody response against a soluble antigen. Interestingly, although the capsid protein lacks a histidine tag, its purification by immobilized metal affinity chromatography was achieved. The formation of VLPs was demonstrated by electron microscopy for the first time for this capsid protein. VLPs were enriched by polyethylene glycol precipitation. Additionally, these VLPs were chemically coupled to green fluorescent protein in order to evaluate them as antigen carriers; however, bioconjugate instability was observed. Nonetheless, the adjuvant effect of these VLPs on BALB/c mice was evaluated, using GFP as antigen, resulting in a significant increase in anti-GFP IgG response, particularly, IgG1 class, demonstrating that the VLPs enhance the immune response against the antigen chosen in this study.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25119647     DOI: 10.1007/s12033-014-9791-8

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  44 in total

1.  Coat protein sequence comparisons of three Medican isolates of papaya ringspot virus with other geographical isolates reveal a close relationship to American and Australian isolates.

Authors:  L Silva-Rosales; N Becerra-Leor; S Ruiz-Castro; D Téliz-Ortiz; J C Noa-Carrazana
Journal:  Arch Virol       Date:  2000       Impact factor: 2.574

Review 2.  The coming of age of virus-like particle vaccines.

Authors:  Gary T Jennings; Martin F Bachmann
Journal:  Biol Chem       Date:  2008-05       Impact factor: 3.915

Review 3.  Chimeric potyvirus-like particles as vaccine carriers.

Authors:  M N Jagadish; S J Edwards; M B Hayden; J Grusovin; K Vandenberg; P Schoofs; R C Hamilton; D D Shukla; H Kalnins; M McNamara; J Haynes; I T Nisbet; C W Ward; D Pye
Journal:  Intervirology       Date:  1996       Impact factor: 1.763

4.  Development of an antigen presentation system based on plum pox potyvirus.

Authors:  M R Fernández-Fernández; J L Martínez-Torrecuadrada; J I Casal; J A García
Journal:  FEBS Lett       Date:  1998-05-08       Impact factor: 4.124

5.  Dual-surface modification of the tobacco mosaic virus.

Authors:  Tara L Schlick; Zhebo Ding; Ernest W Kovacs; Matthew B Francis
Journal:  J Am Chem Soc       Date:  2005-03-23       Impact factor: 15.419

6.  Immunogenicity of papaya mosaic virus-like particles fused to a hepatitis C virus epitope: evidence for the critical function of multimerization.

Authors:  Jérôme Denis; Nathalie Majeau; Elizabeth Acosta-Ramirez; Christian Savard; Marie-Claude Bedard; Sabrina Simard; Katia Lecours; Marilène Bolduc; Christine Pare; Bernard Willems; Naglaa Shoukry; Philippe Tessier; Patrick Lacasse; Alain Lamarre; Réjean Lapointe; Constantino Lopez Macias; Denis Leclerc
Journal:  Virology       Date:  2007-02-22       Impact factor: 3.616

Review 7.  Applications of viral nanoparticles in medicine.

Authors:  Ibrahim Yildiz; Sourabh Shukla; Nicole F Steinmetz
Journal:  Curr Opin Biotechnol       Date:  2011-05-16       Impact factor: 9.740

8.  Improvement of the trivalent inactivated flu vaccine using PapMV nanoparticles.

Authors:  Christian Savard; Annie Guérin; Karine Drouin; Marilène Bolduc; Marie-Eve Laliberté-Gagné; Marie-Christine Dumas; Nathalie Majeau; Denis Leclerc
Journal:  PLoS One       Date:  2011-06-29       Impact factor: 3.240

Review 9.  Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design.

Authors:  Emily M Plummer; Marianne Manchester
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2010-09-24

10.  Mechanisms of action of adjuvants.

Authors:  Sunita Awate; Lorne A Babiuk; George Mutwiri
Journal:  Front Immunol       Date:  2013-05-16       Impact factor: 7.561

View more
  3 in total

Review 1.  Recombinant helical plant virus-based nanoparticles for vaccination and immunotherapy.

Authors:  Kannan Badri Narayanan; Sung Soo Han
Journal:  Virus Genes       Date:  2018-07-14       Impact factor: 2.332

2.  Self-assembly of hexahistidine-tagged tobacco etch virus capsid protein into microfilaments that induce IgG2-specific response against a soluble porcine reproductive and respiratory syndrome virus chimeric protein.

Authors:  Carlos Alberto Manuel-Cabrera; Alba Adriana Vallejo-Cardona; Eduardo Padilla-Camberos; Rodolfo Hernández-Gutiérrez; Sara Elisa Herrera-Rodríguez; Abel Gutiérrez-Ortega
Journal:  Virol J       Date:  2016-11-29       Impact factor: 4.099

3.  Bivalent DNA vaccine induces significant immune responses against infectious hematopoietic necrosis virus and infectious pancreatic necrosis virus in rainbow trout.

Authors:  Liming Xu; Jingzhuang Zhao; Miao Liu; Guangming Ren; Feng Jian; Jiasheng Yin; Ji Feng; Hongbai Liu; Tongyan Lu
Journal:  Sci Rep       Date:  2017-07-18       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.